Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Feb 2026.
- Largest single sale: $1.2M (2,476 shares) of Vertex Pharmaceuticals on Feb 17, 2026. Filing
- Last sale before this period: Oct 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP and Chief Legal Officer | Sep 21, 2022 | Feb 26, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Feb 25, 2026, Vertex Pharmaceuticals: sold 945 shares for $460K, under a disclosed plan. 1 filing: 1
- Feb 24, 2026, Vertex Pharmaceuticals: 1,144 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Vertex Pharmaceuticals: sold 1,244 shares for $589K, under a disclosed plan. 1 filing: 1
- Feb 17, 2026, Vertex Pharmaceuticals: sold 2,476 shares for $1.2M, under a disclosed plan; 4,135 shares granted; 1,505 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Vertex Pharmaceuticals: sold 988 shares for $493K, under a disclosed plan; 2,993 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.